Recce Pharmaceuticals Ltd.'s market cap is currently ―. The company's EPS TTM is AU$-0.063; its P/E ratio is -8.73; Recce Pharmaceuticals Ltd. is scheduled to report earnings on August 30, 2024, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 22	Jun 21	Jun 20	Jun 19	Jun 18
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	-	-	-	-	-
EBITDA	-	-	-	-	-
Net Income Common Stockholders	-	-	-	-	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	AU$ 11.58M	AU$ 20.87M	AU$ 2.68M	AU$ 403.38K	AU$ 679.72K
Total Assets	AU$ 12.62M	AU$ 21.68M	AU$ 3.24M	AU$ 922.18K	AU$ 1.14M
Total Debt	AU$ 74.76K	AU$ 126.95K	AU$ 83.23K	AU$ 0.00	AU$ 0.00
Net Debt	AU$ -11.51M	AU$ -20.75M	AU$ -2.60M	AU$ -403.38K	AU$ -679.72K
Total Liabilities	AU$ 2.56M	AU$ 1.18M	AU$ 931.53K	AU$ 1.33M	AU$ 448.82K
Stockholders Equity	AU$ 10.06M	AU$ 20.50M	AU$ 2.31M	AU$ -405.60K	AU$ 694.91K
Cash Flow	-
Free Cash Flow	-	-	-	-	-
Operating Cash Flow	-	-	-	-	-
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	-	-	-	-

Currency in AUD

Recce Pharmaceuticals Ltd. Earnings and Revenue History

Income Statement >

Recce Pharmaceuticals Ltd. Debt to Assets

Balance Sheet >

Recce Pharmaceuticals Ltd. Cash Flow

Cash Flow >

Recce Pharmaceuticals Ltd. Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing